Resmetirom HPLC Method Validation and Degradation Product Data

figshare hosts a research document detailing the development and validation of a reverse-phase HPLC method for analyzing related substances in the drug resmetirom. The method, validated per ICH guidelines, effectively separates impurities within a 45-minute runtime and identifies a new degradation product, imp-A. The document was authored by Jisu Qin and published under a CC BY 4.0 license.

Use Cases

• Validate the 45-minute HPLC gradient elution method for separating resmetirom and its related substances.
• Analyze the chemical structure of the newly identified degradation product, imp-A, using NMR and HRMS data.
• Apply the ICH-validated method parameters for specificity, linearity, and precision in pharmaceutical quality control.

Strengths

• Method validation follows International Conference on Harmonization (ICH) guidelines, ensuring regulatory relevance.
• The HPLC method achieves effective separation of all impurities within a defined 45-minute runtime.
• Includes first-time reporting of a new degradation product (imp-A) with structural elucidation via NMR and HRMS.

Limitations

• The core data is presented in a 1.1 MB DOCX file, not a structured, machine-readable tabular format.
• No sample dataset, column definitions, or row counts are provided for direct computational analysis.
• The document's primary focus is methodological validation rather than a large-scale experimental results dataset.

Provenance

Source

Jisu Qin via figshare.

Collection Method

Laboratory analysis using RP-HPLC, NMR, and HRMS for method development and validation.

Freshness

Last updated on 2026-03-24.